| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/04/2012 | EP2401035A1 Antibodies specifically directed to the soluble form of ctla-4 |
| 01/04/2012 | EP2400971A1 Treatment of immunosuppression-related disorders |
| 01/04/2012 | EP2400960A1 Ceramide-analogous metabolites |
| 01/04/2012 | EP2078026B1 Prodrug salts of 2, 4-pyrimidinediamine compounds and their uses |
| 01/04/2012 | EP2049502B1 2,4-substituted quinazolines as lipid kinase inhibitors |
| 01/04/2012 | EP1814878B1 Spiro-2, 4-pyrimidinediamine compounds and their uses |
| 01/04/2012 | CN1558765B Enantiomerically pure opioid diarylmethylpiperzine and methods of using same |
| 01/04/2012 | CN102307896A Fibronectin type III domain based scaffold compositions, methods and uses |
| 01/04/2012 | CN102307894A A variant of mite allergen and uses thereof |
| 01/04/2012 | CN102307871A Isoindolinone and related analogs as sirtuin modulators |
| 01/04/2012 | CN102307586A Compounds and methods for the treatment of autoimmune and inflammatory disease |
| 01/04/2012 | CN102304458A Vitality-retention wine and preparation method thereof |
| 01/04/2012 | CN102304158A Acylated flavonoid glycoside compounds and application thereof in preparation of complement inhibitor medicines |
| 01/04/2012 | CN102304124A Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 01/04/2012 | CN102302785A Preparation method of water-soluble hypericin supramolecular inclusion compound |
| 01/04/2012 | CN102302676A Beautifying and nutritious liquor |
| 01/04/2012 | CN102302648A Traditional Chinese medicine composition for treating allergic rhinitis |
| 01/04/2012 | CN102302630A Chinese patent medicine used for increasing leucocytes and enhancing immunity |
| 01/04/2012 | CN102302625A Medicament for treating infantile eczema |
| 01/04/2012 | CN102302609A Compound traditional Chinese drug preparation for improving subhealth |
| 01/04/2012 | CN102302574A Medicament for reinforcing immunity |
| 01/04/2012 | CN102302561A Method for preparing belvedere fruit total saponins |
| 01/04/2012 | CN102302540A Health-care product for reinforcing immunity |
| 01/04/2012 | CN102302532A Extraction technologcial method of glucosinolate in canola meal |
| 01/04/2012 | CN102302522A Method for purifying ginkgo flavones through membrane separation |
| 01/04/2012 | CN102302519A Propolis nano-emulsion and preparation method thereof |
| 01/04/2012 | CN102302497A Preparation for treating allergic rhinitis and preparation method thereof |
| 01/04/2012 | CN102302496A Applications of isoquinoline-type alkaloid and derivatives thereof in preparing medicaments for preventing or treating cervical cancer |
| 01/04/2012 | CN102302494A Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 01/04/2012 | CN102302493A Methods to mobilize progenitor/stem cells |
| 01/04/2012 | CN102302474A Orally administered danazol sustained-release capsule and preparation method thereof |
| 01/04/2012 | CN102302460A Methylprednisolone sodium succinate freeze dried powder injection and preparation method thereof |
| 01/04/2012 | CN102058625B High-efficient anti-stress agent for aquaculture |
| 01/04/2012 | CN101978979B Method for preparing refined celery extract |
| 01/04/2012 | CN101934046B Semifluid extract of deer foetus and preparation method thereof |
| 01/04/2012 | CN101920017B Composite for promoting glycyrrhetinic acid to realize percutaneous permeation |
| 01/04/2012 | CN101829138B Composition for strengthening immune regulation function in human body and applications thereof |
| 01/04/2012 | CN101632662B Sirolimus preparation and preparation process thereof |
| 01/04/2012 | CN101518552B Pine pollen and cyclodextrin composition, method for preparing same, use of same in preparation of health-care products for resisting fatigue and improving immunity of organisms |
| 01/04/2012 | CN101486687B Preparation technique of setastine hydrochloride |
| 01/03/2012 | US8088924 Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor |
| 01/03/2012 | US8088905 Nucleic acids encoding antibodies against PD-1 |
| 01/03/2012 | US8088825 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 01/03/2012 | US8088780 5,7-disubstituted thiazolo[4,5-D]pyrimidines for the selective inhibition of chemokine receptors |
| 01/03/2012 | US8088761 Enzyme inhibitors |
| 01/03/2012 | US8088407 Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| 01/03/2012 | US8088388 Complexing; water in oil emulsion; immunostimulant |
| 01/03/2012 | US8088383 Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies |
| 01/03/2012 | US8088377 Human monoclonal antibodies against CD30 |
| 01/03/2012 | CA2690293C Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage |
| 01/03/2012 | CA2632556C Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 01/03/2012 | CA2576256C Immunomodulating oxopyrrazolocinnolines as cd80 inhibitors |
| 01/03/2012 | CA2514558C Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology |
| 01/03/2012 | CA2512441C Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 01/03/2012 | CA2496902C Medicament for activating the phagocytic capacity of macrophages |
| 01/03/2012 | CA2488565C Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 01/03/2012 | CA2466054C Apo-2 ligand/trail formulations |
| 01/03/2012 | CA2465117C Lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
| 01/03/2012 | CA2457719C Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 01/03/2012 | CA2455972C N6-benzyl and phenyl substituted adenines and their use as cosmetics, pharmaceutical preparations and plant growth regulators |
| 01/03/2012 | CA2436049C A serpin in bifidobacteria |
| 01/03/2012 | CA2420949C Peptide selection method |
| 01/03/2012 | CA2404108C A method of preparing vaccines |
| 01/03/2012 | CA2397661C 2,4-disubstituted thiazolyl derivatives |
| 01/03/2012 | CA2395684C Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 01/03/2012 | CA2348658C Vaccine preparations containing attenuated toxin |
| 01/03/2012 | CA2334960C Combination of tgf-.beta. inhibition and immune stimulation to treat hyperproliferative diseases |
| 01/03/2012 | CA2304952C Mannose-receptor bearing cells and antigen conjugate for immunotherapy |
| 01/03/2012 | CA2284000C Hydrophilic binary systems for the administration of cyclosporine |
| 12/29/2011 | WO2011163600A2 Tacrolimus compositions for aerosol administration |
| 12/29/2011 | WO2011163533A2 One step removal of selected molecules from body fluid and tissue |
| 12/29/2011 | WO2011162835A1 Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors |
| 12/29/2011 | WO2011162639A1 Heterochain aliphatic poly-n-oxide copolymers and vaccinating agents and drugs based thereon |
| 12/29/2011 | WO2011162320A1 Combination of egcg or methylated egcg and a pde inhibitor |
| 12/29/2011 | WO2011162300A1 Crystal of fused pyridine compound salt |
| 12/29/2011 | WO2011162274A1 Isoquinoline derivative |
| 12/29/2011 | WO2011162222A1 Novel crystalline forms of 4,4'-[4-fluoro-7-({4-[4-(3-fluoro-2-methylphenyl)butoxy]phenyl}ethynyl)-2-methyl-1h-indole-1,3-diyl]dibutanoic acid, 4,4'-[2-methyl-7-({4-[4-(pentafluorophenyl)butoxy]phenyl}ethynyl)-1h-indole-1,3-diyl]dibutanoic acid, and 4,4'-[4-fluoro-2-methyl-7-({4-[4-(2,3,4,6-tetrafluorophenyl)butoxy]phenyl}ethynyl)-1h-indole-1,3-diyl]dibutanoic acid |
| 12/29/2011 | WO2011161645A1 5-lipoxygenase inhibitors |
| 12/29/2011 | WO2011161266A1 Improved immunoglobulin single variable domains and constructs thereof directed against cxcr4 |
| 12/29/2011 | WO2011161031A1 Benzotriazolodiazepine compounds inhibitors of bromodomains |
| 12/29/2011 | WO2011160632A1 Benzodioxole or benzodioxepine heterocyclic compounds phosphodiesterase inhibitors |
| 12/29/2011 | WO2011160170A1 Stimulating immune response |
| 12/29/2011 | WO2011138785A3 Use of ccl1 in therapy |
| 12/29/2011 | WO2011103524A3 Cyclic tetrapeptides and therapeutic applications thereof |
| 12/29/2011 | WO2011097571A3 Methods for the use of progestogen as a glucocorticoid sensitizer |
| 12/29/2011 | WO2011090973A3 Immunotherapy compositions and methods of treatment |
| 12/29/2011 | WO2011041634A8 Pyrazole inhibitors of phosphatidylinositol 3-kinase |
| 12/29/2011 | WO2010142030A8 Different serotypes of vesicular stomatitis virus as expression vectors for immunization regimens |
| 12/29/2011 | US20110319486 Stabilized ascorbic acid solutions; method of use thereof; process for their obtention; and compositions comprising the same |
| 12/29/2011 | US20110319480 Method of Inducing and/or Enhancing an Immune Response to Tumor Antigens |
| 12/29/2011 | US20110319476 Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf |
| 12/29/2011 | US20110319446 Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses |
| 12/29/2011 | US20110319431 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 12/29/2011 | US20110319413 Piperazine compound capable of inhibiting prostaglandin d synthase |
| 12/29/2011 | US20110319410 Pyrazine derivatives and use as pi3k inhibitors |
| 12/29/2011 | US20110319381 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof |
| 12/29/2011 | US20110319377 Controlled Release Corticosteroid Compositions and Methods for the Treatment of Otic Disorders |
| 12/29/2011 | US20110319363 Novel phosphonic acid compounds as inhibitors of serine proteases |
| 12/29/2011 | US20110319330 Methods For Treating Arthritis, Autoimmune Disease, and Ischemia-Reperfusion Injury |
| 12/29/2011 | US20110319321 Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof |